Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
China Bio-Immunity CORPListing unverified | Other | $4B | SEC |